A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas (Q33409608)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas |
scientific article |
Statements
1 reference
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas (English)
1 reference
Jane N Winter
1 reference
Steven T Rosen
1 reference
Irene Helenowski
1 reference
Justin Kline
1 reference
Annette Larsen
1 reference
Jennifer Colvin
1 reference
Koen M van Besien
1 reference
Sonali M Smith
1 reference
8 August 2013
1 reference
1 reference
163
1 reference
55-61
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference